<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-04-15">April 15, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Erik</forename><surname>Biros</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Medicine and Dentistry</orgName>
								<orgName type="laboratory">The Queensland Research Centre for Peripheral Vascular Disease</orgName>
								<orgName type="institution">James Cook University</orgName>
								<address>
									<settlement>Townsville</settlement>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gabor</forename><surname>Gäbel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Vascular and Endovascular Surgery</orgName>
								<orgName type="institution">Ludwig-Maximillian University</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Corey</forename><forename type="middle">S</forename><surname>Moran</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">College of Medicine and Dentistry</orgName>
								<orgName type="laboratory">The Queensland Research Centre for Peripheral Vascular Disease</orgName>
								<orgName type="institution">James Cook University</orgName>
								<address>
									<settlement>Townsville</settlement>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charlotte</forename><surname>Schreurs</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Vascular Surgery</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><forename type="middle">H N</forename><surname>Lindeman</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Vascular Surgery</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philip</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Royal Brisbane Clinical School</orgName>
								<orgName type="institution">The University of Queensland</orgName>
								<address>
									<settlement>Queensland</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Nataatmadja</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="laboratory">The Cardiovascular Research Group</orgName>
								<orgName type="institution">The University of Queensland</orgName>
								<address>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Malcolm</forename><surname>West</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="laboratory">The Cardiovascular Research Group</orgName>
								<orgName type="institution">The University of Queensland</orgName>
								<address>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lesca</forename><forename type="middle">M</forename><surname>Holdt</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Laboratory Medicine</orgName>
								<orgName type="institution">Ludwig Maximilians University Munich</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Irene</forename><surname>Hinterseher</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of General, Visceral, Vascular and Thoracic Surgery</orgName>
								<orgName type="institution" key="instit1">Charité Universitätsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Charité Campus Mitte</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Pilarsky</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Vascular</orgName>
								<orgName type="department" key="dep2">Thoracic and Visceral Surgery</orgName>
								<orgName type="institution">TU-Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Jonathan</forename><surname>Golledge</surname></persName>
							<email>jonathan.golledge@jcu.edu.au</email>
							<affiliation key="aff0">
								<orgName type="department">College of Medicine and Dentistry</orgName>
								<orgName type="laboratory">The Queensland Research Centre for Peripheral Vascular Disease</orgName>
								<orgName type="institution">James Cook University</orgName>
								<address>
									<settlement>Townsville</settlement>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Vascular and Endovascular Surgery</orgName>
								<orgName type="institution">The Townsville Hospital</orgName>
								<address>
									<settlement>Townsville</settlement>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-04-15">April 15, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">853178698745D9F718736B82D3E0A877</idno>
					<note type="submission">Received: March 02, 2015 Accepted: March 21, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>aortic aneurysm</term>
					<term>abdominal</term>
					<term>arterial occlusive diseases</term>
					<term>tissue array analysis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Abdominal aortic aneurysm (AAA) and aortic occlusive disease (AOD) represent common causes of morbidity and mortality in elderly populations which were previously believed to have common aetiologies.</s><s>The aim of this study was to assess the gene expression in human AAA and AOD.</s><s>We performed microarrays using aortic specimen obtained from 20 patients with small AAAs (≤ 55mm), 29 patients with large AAAs (&gt; 55mm), 9 AOD patients, and 10 control aortic specimens obtained from organ donors.</s><s>Some differentially expressed genes were validated by quantitative-PCR (qRT-PCR)/immunohistochemistry.</s><s>We identified 840 and 1,014 differentially expressed genes in small and large AAAs, respectively.</s><s>Immune-related pathways including cytokine-cytokine receptor interaction and T-cell-receptor signalling were upregulated in both small and large AAAs.</s><s>Examples of validated genes included CTLA4 (2.01-fold upregulated in small AAA, P = 0.002), NKTR (2.37-and 2.66-fold upregulated in small and large AAA with P = 0.041 and P = 0.015, respectively), and CD8A (2.57-fold upregulated in large AAA, P = 0.004).</s><s>1,765 differentially expressed genes were identified in AOD.</s><s>Pathways upregulated in AOD included metabolic and oxidative phosphorylation categories.</s><s>The UCP2 gene was downregulated in AOD (3.73-fold downregulated, validated P = 0.017).</s><s>In conclusion, the AAA and AOD transcriptomes were very different suggesting that AAA and AOD have distinct pathogenic mechanisms.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IntroductIon</head><p><s>Peripheral arterial diseases include a collection of occlusive and aneurysmal diseases affecting arteries outside the heart estimated to affect approximately 5% of adults <ref type="bibr" target="#b0">[1]</ref>.</s><s>The mechanisms responsible for ischemic complications of peripheral artery atherosclerosis are believed to be similar to those implicated in coronary atherosclerosis <ref type="bibr" target="#b1">[2]</ref>.</s><s>In keeping with the perceived similar pathogenesis of coronary and peripheral artery disease most of the drug therapies used in patients with these conditions are the same <ref type="bibr" target="#b2">[3]</ref>.</s><s>The mechanisms involved in abdominal aortic aneurysm (AAA) development and their relationship with atherosclerosis are however controversial <ref type="bibr" target="#b3">[4]</ref>.</s><s>Examination of human AAA biopsies has consistently identified concurrent intimal atherosclerosis and most AAAs have been considered to result from atherosclerosis <ref type="bibr">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Some of the risk factors for atherosclerosis and AAA are however distinct, for example diabetes an important positive risk factor for occlusive artery disease is a negative risk factor for AAA <ref type="bibr" target="#b3">[4,</ref><ref type="bibr">5]</ref>.</s><s>Dyslipidemia is also believed to be a less important risk factor for AAA than atherosclerotic occlusive disease <ref type="bibr" target="#b6">[7]</ref>.</s><s>There are also a number of similarities between atherosclerosis and AAA, including common risk factors of smoking, hypertension, and male gender <ref type="bibr">[5,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>The role of atherosclerosis in AAA therefore is currently controversial <ref type="bibr" target="#b3">[4]</ref>.</s></p><p><s>Examination of mechanisms involved in AAA has mainly relied on use of animal, particularly rodent, models <ref type="bibr" target="#b9">[10]</ref>.</s><s>The availability of whole genome expression profiling has allowed insight into a range of human pathologies but has been relatively sparingly applied to AAA and aortic atherosclerosis <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>. Two previous studies have examined the whole genome expression profile of human AAA specimen although sample sizes for these studies were relatively small totaling 7 and 10 AAA patients, and no comparison was performed with atherosclerosis <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>In the current study we examined the whole genome expression profiles of a relatively large number of human aortic biopsies from subjects undergoing surgery to repair AAAs and to treat chronic lower limb ischemic due to aortic atherosclerosis (aortic occlusive disease, AOD).</s><s>Aortic wall samples obtained from organ donors were used as controls.</s><s>We aimed to compare the aortic gene expression profile of patients with AAA and AOD to those of older subjects with normal aortic histology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient characteristics</head><p><s>The gene expression was initially assessed in the aortic biopsies of 20 patients with small AAAs (mean AAA diameter 53.4±2.3 mm), 29 patients with large AAAs (mean AAA diameter 68.4±14.3</s><s>mm), 9 patients with AOD (mean aortic diameter 19.6±2.6 mm), and 10 control organ donors using microarrays (Table <ref type="table" target="#tab_1">1</ref>).</s><s>AAA patients were less likely to be female compared to controls (small AAA 0%, large AAA 7%, controls 40%; P &lt; 0.05), while AOD patients were younger compared to controls (mean age 61.6±9.3 vs. 68.4±4.5 years, P &lt; 0.05).</s><s>The validity of microarray findings was further assessed in biopsies obtained from 6 patients with small AAAs, 9 patients with large AAAs, 8 AOD patients, and 6 controls (Table <ref type="table" target="#tab_1">1</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Numerical assessment of gene expression profiles in small AAAs, large AAAs, and Aod</head><p><s>A total of 39,157 transcripts in small AAAs, 39,389 transcripts in large AAAs, 37,904 transcripts in AOD, and 36,725 transcripts in control samples, representing &gt; 80% of the Illumina HumanHT-12 v4 Expression BeadChip reference list, were expressed above background and subjected to differential gene expression analysis.</s><s>A total of 840 individual genes were differentially expressed (≥ 2.0-fold, adjusted P &lt; 0.05) in small AAAs compared to controls (122 upregulated and 718 downregulated genes; Figure <ref type="figure" target="#fig_1">1a</ref> and 1b, respectively).</s><s>A total of 1,014 individual genes were differentially expressed (≥ 2.0 fold, adjusted P &lt; 0.05) in large AAAs compared to controls (215 upregulated and 799 downregulated genes; Figure <ref type="figure" target="#fig_1">1a</ref> and 1b, respectively).</s><s>1,765 individual genes were differentially expressed (≥ 2.0-fold, adjusted P &lt; 0.05) in AOD compare to controls (1,677 upregulated and 88 downregulated genes; Figure <ref type="figure" target="#fig_1">1a</ref> and 1b, respectively).</s><s>Full lists of differentially expressed genes are given in Supplemental Table <ref type="table">I</ref>, Supplemental Table <ref type="table">II</ref>, and Supplemental Table <ref type="table">III</ref> for small AAA, large AAA, and AOD, respectively.</s><s>A preponderance of genes upregulated in small AAAs (100/122; 82%) were also upregulated in large AAAs.</s><s>Approximately 47% (100/215; Figure <ref type="figure" target="#fig_1">1a</ref>) of the genes upregulated in large AAAs were also upregulated in small AAAs.</s><s>In contrast only one gene (CXCL12) differentially expressed in AOD samples (1/1,765) was also differentially expressed in small (1/840) or large (1/1,014) AAAs (Figure <ref type="figure" target="#fig_1">1a and 1b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pathways related to the differentially expressed genes in small and large AAA</head><p><s>We performed an enrichment analysis of differentially expressed genes with particular attention www.impactjournals.com/oncotarget  to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways to assess the biological contexts of these genes.</s><s>KEGG annotations included 93% (114/122) of upregulated genes and 92% (661/718) of downregulated genes in small AAAs; and 91% (196/215) of upregulated genes and 95% (756/799) of downregulated genes in large AAA samples.</s><s>The KEGG analysis revealed marked upregulation of genes related to immune responses in both small and large AAA.</s><s>These pathways included cytokinecytokine receptor interaction (hsa04060; P = 1.15*10 -14 for small AAA, and P = 2.52*10 -17 for large AAA), chemokine signaling pathway (hsa04062; P = 4.50*10 -11 for small AAA, and P = 3.53*10 -12 for large AAA), and T-cell receptor signaling pathway (hsa04660; P = 4.07*10 -05 for small AAA, and P = 2.40*10 -06 for large AAA) as shown in Table <ref type="table" target="#tab_2">2</ref>. Metabolic pathways (hsa01100) and oxidative phosphorylation (hsa00190) were found among the top 10 most significant KEGG categories enriched by downregulated genes with P = 2.30*10 -22 (metabolic pathways) and P = 4.25*10 -20 (oxidative phosphorylation) for small AAA; and P = 1.05*10 -24 (metabolic pathways) and P = 8.60*10 -20 (oxidative phosphorylation) for large AAA (Table <ref type="table" target="#tab_2">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>differentially expressed genes in small and large AAA</head><p><s>Considering the marked enrichment of immune response categories in small and large AAA, we further examined a number of genes related to the immune response (Table <ref type="table" target="#tab_3">3</ref>).</s><s>A majority of genes upregulated in small AAA were also upregulated in large AAA.</s><s>Examples include genes coding for: pro-inflammatory cytokines IL1B (5.08-fold, P = 0.002 for small AAA; 3.85-fold, P = 0.001 for large AAA), IL6 (6.28-fold, P = 0.004 for small AAA; 6.48-fold, P = 0.002 for large AAA), and IL8 (4.49fold, P = 0.005 for small AAA; 3.65-fold, P = 0.004 for large AAA); chemokines CXCL2 (3.35-fold, P = 0.004 for small AAA; 2.73-fold, P = 0.005 for large AAA), CXCL13 (2.21-fold, P = 0.013 for small AAA; 3.09-fold, P = 0.002 for large AAA), CCL3L3 (3.14-fold, P = 0.039 for small AAA; 2.59-fold, P = 0.041 for large AAA), and CCL4L2 (2.48-fold, P = 0.021 for small AAA; 2.12-fold, P = 0.023 for large AAA); early T-cell and B-cell activation cluster of differentiation (CD) antigens CD69 (2.67-fold, P = 0.039 for small AAA; 3.45-fold, P = 0.004 for large AAA) and CD19 (2.79-fold, P = 0.026 for small AAA; 4.45-fold, P = 0.002 for large AAA), respectively; and the natural killer (NK) cells associated protein NKTR (2.37fold, P = 0.002 for small AAA; 2.66-fold, P = 0.001 for large AAA).</s><s>An important negative regulator of T-cells responses, the CTLA4 gene, was exclusively upregulated in small AAA (2.01-fold, P = 0.018).</s><s>On the other hand, there was increased expression of genes related to T-cell and B-cell responses exclusively in large AAA, including alpha chain of the T-cell co-receptor CD8A (2.24-fold, P = 0.012); the CD79A/CD79B membrane-bound dimer immunoglobulin in B-cells (2.76-fold, P = 0.005/3.43fold,</s><s>P = 0.004); the receptors for Fc fragment of IgG in B-cells FCRL2 (2.53-fold, P = 0.002), FCRL5 (2.01-fold, P = 0.001), and FCRLA (3.15-fold, P = 0.009).</s><s>Three genes (CTLA4, NKTR, and CD8A) were selected for further validation with quantitative real-time PCR.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pathways related to the differentially expressed genes in Aod</head><p><s>92% (1,550/1,677) of upregulated genes and 90% (79/88) of downregulated genes in AOD samples were annotated in the KEGG pathways.</s><s>The pathways enriched in AOD samples were distinct to those identified in AAA samples.</s><s>In AOD, the most significant KEGG categories representing upregulated genes were metabolic pathways (hsa01100; P = 1.49*10 -43 ) and oxidative phosphorylation (hsa00190; P = 5.68*10 -35 ).</s><s>Downregulated genes primarily fell into the immune response categories such as cytokine-cytokine receptor interaction (hsa04060; P = 5.69 -07 ) and chemokine signaling pathways (hsa04062; P = 8.64*10 -06 ) as seen in Table <ref type="table" target="#tab_4">4</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>differentially expressed genes in Aod</head><p><s>Inspection of genes within KEGG metabolic categories revealed upregulation of genes related to mitochondrial biogenesis that included many members of all five mitochondrial respiratory and ATP production complexes (Table <ref type="table" target="#tab_5">5</ref>).</s><s>We also demonstrated the upregulation of numerous genes involved in glycolysis/ gluconeogenesis, fatty acid metabolism, and propanoate metabolism (Table <ref type="table" target="#tab_5">5</ref>).</s><s>Several complement system genes were overexpressed such as C1S (2.08-fold, P = 0.044), CD46 (2.00-fold, P = 0.004), CFH (2.81-fold, P = 0.006), CFI (2.02-fold, P = 0.004), C1QBP (2.10-fold, P = 0.003), C1RL (2.08-fold, P = 0.003), and C7 (3.46fold, P = 0.037).</s><s>One important mitochondrial regulatory gene called mitochondrial uncoupling protein 2 (UCP2) was downregulated in AOD samples (-3.73-fold,</s><s>P = 0.014), (Table <ref type="table" target="#tab_5">5</ref>).</s><s>The UCP2 gene was selected for further validation with quantitative real-time PCR.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>real time Pcr</head><p><s>Expression levels of a number of genes were validated in biopsies from the six patients with small AAAs, nine patients with large AAAs, eight patients with AOD and six controls (Table <ref type="table" target="#tab_1">1</ref>).</s><s>The relative expression of CTLA4 was significantly increased in small AAA but not large AAA biopsies compared to normal controls (Table <ref type="table" target="#tab_6">6</ref>).</s><s>Median relative expression of CTLA4 was also markedly increased in small AAA versus large AAA biopsies (202.161 vs. 65.239,</s><s>P = 0.041).</s><s>The relative expression of CD8A was significantly increased in large AAA but not small AAA biopsies compared to normal controls (Table <ref type="table" target="#tab_6">6</ref>), with the median relative expression of CD8A in large AAA ~2-fold higher and approaching significance compared to small AAA (109.489</s><s>vs 61.004; P = 0.065).</s><s>Correspondingly, immunohistochemical examination of AAA tissue demonstrated marked presence of CD8-positive T lymphocytes within the adventitia and outer media of a large (82mm) AAA (Figure <ref type="figure" target="#fig_0">2A</ref>) with limited immunostaining for CTLA4 (Figure <ref type="figure" target="#fig_0">2C</ref>).</s><s>In contrast there was relatively sparse presence of CD8positive T cells within tissue from a small (55mm) AAA (Figure <ref type="figure" target="#fig_0">2B</ref>) but marked CTLA4 staining around tertiary lymphoid tissue at the media-adventia border (Figure <ref type="figure" target="#fig_0">2D</ref>).</s><s>Median relative expression of NKTR was significantly greater in AAA biopsies compared to normal controls with approximately 2-(P = 0.041) and 3-(P = 0.015) fold increase for small and large AAAs, respectively (Table <ref type="table" target="#tab_6">6</ref>).</s><s>Median relative expression of NKTR was also markedly increased in large AAA compared to small AAA biopsies (1.186 vs. 0.651, P = 0.040).</s></p><p><s>The relative expression of UCP2 was markedly decreased in AOD samples compared to normal controls (Table <ref type="table" target="#tab_6">6</ref>).</s><s>In subjects with AOD the UCP2 mRNA expression was more than 3-fold lower compared to the control aortic biopsies (0.739 vs. 2.306, P = 0.017).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>dIscussIon</head><p><s>Human AAA biopsies have been consistently shown to have intimal atheroma and historically AAAs have been considered to result from atherosclerosis <ref type="bibr">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>However the mechanisms involved in AAA development and its relationship with atherosclerosis remain controversial <ref type="bibr" target="#b3">[4]</ref>.</s><s>We determined the global gene expression profiles within biopsies of AAA and AOD using microarrays.</s><s>The main finding from this study was that the genes differentially expressed in AAA and AOD were almost completely distinct, supporting the concept of separate developmental mechanisms underlying the pathogenesis of each disease <ref type="bibr" target="#b3">[4]</ref>.</s><s>With this in mind, global gene expression profiles associated with AAA and AOD will be further discussed separately.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AAA</head><p><s>A number of human and animal studies previously suggested a major role of immune responses in AAA pathogenesis <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref> and the array findings for cytokines/ chemokines are in line with previous quantitative data <ref type="bibr" target="#b17">[18]</ref>.</s><s>Our results substantiate those findings, and more importantly, suggest also that small AAAs (≤ 55 mm) and large AAAs (&gt; 55 mm) may have some distinct immunological characteristics.</s><s>The most notable finding related to immunity was that the key T-cell regulatory gene called cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CD152) was exclusively found to be upregulated in small AAAs.</s><s>Moreover, our data suggests excessive infiltration of CD8 + T-cells in biopsies from large AAAs evidenced by the exclusive overexpression of the gene coding for the CD8A molecule and increased number of CD8+ T-cells found in these specimens.</s><s>The upregulation of CTLA4 and CD8A in small AAA and large AAA, respectively, was confirmed by qRT-PCR and led us to hypothesize that downregulation of CTLA4 may represent a key mechanism in AAA progression which promotes excessive T-cell-driven immune responses in large AAAs.</s><s>This hypothesis is supported by our finding of marked downregulation of the CTLA4 mRNA and the protein product in large AAAs compared to small AAAs as determined by qRT-PCR and immunohistochemistry, respectively.</s><s>CTLA4 is a cell surface molecule that can down-modulate and terminate T-cell adaptive immunity <ref type="bibr" target="#b18">[19]</ref>.</s><s>The CD8A molecule is a constituent of the CD8 antigen found on most cytotoxic T lymphocytes and acts as a co-receptor with the T-cell receptor (TCR).</s><s>Previous immunohistochemical studies of human AAA have provided evidence that CD8 + T-cells infiltrating the aortic wall express cytotoxic mediators such as perforins, which generate membrane damage <ref type="bibr" target="#b19">[20]</ref>.</s><s>Other studies have shown that immunosuppressive agents directed exclusively at T-cells are capable of reducing the expansion of experimental AAA <ref type="bibr" target="#b20">[21]</ref> and reduce vascular inflammation and aortic wall content of several inflammatory cell types including cytotoxic T lymphocytes in human AAA <ref type="bibr" target="#b21">[22]</ref>.</s><s>Taken together, the manipulation of CTLA4 levels may represent a novel therapeutic strategy for AAAs but this need examining in other contexts e.g.</s><s>animal models.</s><s>The use of CTLA4-based biologic agents such as Abatacept (Orencia), a novel fusion protein of the Fc region of the immunoglobulin IgG1 and CTLA4 designed to downregulate T-cells activity, is already under investigation as a potential therapy for other immunopathologies such as active rheumatoid arthritis <ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref>. Findings from the present study additionally demonstrate the upregulation of genes expressed by NK cells within large AAAs, such as natural killer cell group 7 sequence (NKG7) and natural killer-tumor recognition sequence (NKTR) genes; both involved in the TCR-independent innate immune responses.</s><s>The latter was assessed and validated to be upregulated in large AAAs by qRT-PCR.</s><s>It is possible that similar mechanisms involving the upregulation of innate immunity occur at some point between the late and end-stage of AAA.</s><s>Findings suggest marked upregulation of the NKTR gene in large AAA compared to small AAA biopsies which is in accord with this hypothesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aod</head><p><s>Genes differentially expressed in AOD versus control samples were particularly related to the metabolic and oxidative phosphorylation pathways which accounted for ~12% of all upregulated genes.</s><s>In particular, we determined the excessive transcription of genes involved in mitochondrial biogenesis affecting numerous members of all four mitochondrial respiratory complexes as well as genes responsible for ATP synthesis in the mitochondrial complex V.</s><s>Other pathways enriched included those related to Parkinson's disease.</s><s>Genes involved in this category belonging to the mitochondrial complex I were upregulated in AOD, contrasting the actual disruption of the mitochondrial complex I in Parkinson's disease itself <ref type="bibr" target="#b27">[28]</ref>.</s><s>We also demonstrated the upregulation of a range www.impactjournals.com/oncotarget of genes involved in glycolysis, gluconeogenesis, fatty acid metabolism, and propanoate metabolism.</s><s>Since the number of overlapping genes in these metabolic pathways is considerable, it would be reasonable to suggest that overexpression of these genes may simply represent a metabolic maladaptation to the excessive mitochondrial biogenesis, as members of these bioenergetic pathways are tightly coordinated transcriptionally <ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref>.</s><s>Upregulation of genes related to glucose and fatty acids metabolism is highly relevant to AOD.</s><s>The role of an impaired glucose tolerance and fatty acids metabolism in atherosclerosis is long-documented <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>Current evidence suggests that the ataxia telangiectasia mutated (ATM)/mammalian target of rapamycin (mTOR) signaling axis may play an important role in suppression of macrophage transformation into foam cells, thus limiting the formation of atherosclerotic plaques <ref type="bibr" target="#b33">[34]</ref>.</s><s>Interestingly, the old malaria drug Chloroquine (Aralen), a lysosomotropic agent that activates ATM signaling, was found to be capable of decreasing atherosclerosis and improving metabolic phenotype in mice <ref type="bibr" target="#b34">[35]</ref>.</s><s>The hypothesis that Chloroquine may also reduce atherosclerosis in humans is currently under investigation <ref type="bibr" target="#b35">[36]</ref>.</s><s>The mechanisms responsible for upregulation of genes involved in mitochondrial biogenesis are not evident in the current study; however, we did identify downregulation of the UCP2 gene in AOD samples.</s><s>The UCP2 protein belongs to a group of mitochondrial transporters that create proton leaks across the inner mitochondrial membrane, thus uncoupling respiration from ATP synthesis <ref type="bibr" target="#b36">[37]</ref>.</s><s>Previous studies provide evidence that uncoupling by UCP2 downregulates the production of reactive oxygen species (ROS) in endothelial and smooth muscle cells <ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref>, whereas the UCP2 deficiency is associated with enhanced ROS production in the endothelium of the aorta <ref type="bibr" target="#b42">[43]</ref>.</s><s>Excessive ROS production is known to contribute to the oxidative damage of mitochondria that needs to be repaired to maintain intact cellular mitochondrial content <ref type="bibr" target="#b43">[44]</ref>.</s><s>This process is accomplished via mitophagy (autophagy), a selective elimination of malfunctioning mitochondria, which must be balanced by mitochondrial biogenesis to meet tissue energy requirements <ref type="bibr" target="#b44">[45]</ref>.</s><s>It is possible that UCP2 deficiency may, in fact, indirectly lead to increased mitochondrial biogenesis, explaining the upregulation of genes related to the metabolic and oxidative phosphorylation pathways in AOD.</s><s>Pathways related to inflammation were less evident amongst differentially expressed genes in AOD samples.</s><s>We did demonstrate the upregulation of a number of complement regulatory and effectors genes, such as complement regulatory protein CD46, complement factor H (CFH), and complement factor I (CFI) suggesting potential involvement of the classical complement activation pathway in AOD.</s><s>The overexpression of the complement component 7 (C7) gene, a constituent of the membrane attack complex (MAC), may indicate the culmination of the alternative complement activation pathway in AOD.</s><s>Findings are in line with previous studies that have suggested an important role for the complement system in mediating tissue injury and atherosclerosis after oxidative stress <ref type="bibr" target="#b46">[46,</ref><ref type="bibr" target="#b47">47]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>limitation of the study</head><p><s>The current study has a number of limitations.</s><s>The available sample size was relatively small especially for AOD although larger than any previously published microarrays using human aortic biopsies.</s><s>In view of this limitation we sought to validate important findings in further groups of AAA and AOD biopsies.</s><s>The assessment of independent samples helps to minimize the possibility that selection biases adversely affect the generalizability of the findings.</s><s>Furthermore, we were able to obtain the aortic biopsies from advanced stage disease including AAAs measuring at least 50mm and patients needing aortic bypass for peripheral ischemia.</s><s>Our findings therefore are difficult to relate to early stage vascular disease.</s><s>The majority of available AAA and AOD biopsies were obtained from men limiting the relevance of our findings to AAA and AOD in women.</s><s>Finally, the AOD patients were either younger (discovery group) or older (validation group) than their respective controls.</s><s>In both particular comparisons of cases with controls, however, an important gene regulating mitochondrial biogenesis was found to be downregulated in AOD, suggesting that our findings are descriptive of the disease rather than age differences between cases and controls.</s></p><p><s>In conclusion, the current results demonstrate distinct gene expression profiles of AAA and AOD.</s><s>The AAA transcriptome highlights an important mechanism controlling immune responses as opposed to the mitochondrial biogenesis pathways being predominantly associated with AOD pathology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAterIAls And Methods</head><p><s>A detailed description of all methods is presented in the online data supplement.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p><s>Full thickness abdominal aortic specimens were obtained from 49 patients undergoing open surgery to treat AAA, 9 patients with AOD undergoing surgery to treat chronic lower limb ischemia, and 10 control individuals (discovery group, Table <ref type="table" target="#tab_1">1</ref>).</s><s>Maximum aortic diameter was 50-55mm (defined as small AAA) and 56-120mm (defined as large AAA) in 20 and 29 AAA subjects, respectively.</s><s>Control full thickness abdominal aortic samples were obtained during kidney transplant (all from heart-beating, brain-dead donors).</s><s>The study was approved by the ethics committees of the Townsville Hospital, James Cook University, Royal Brisbane and Women's Hospital, Medical Faculty at the Technical University Dresden, and Leiden University Medical Center and the protocol conformed to ethical guidelines of Declaration of Helsinki.</s><s>All patients gave written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microarrays</head><p><s>Microarrays were performed using the Illumina HumanHT-12v4 Expression BeadChip ® platform as previously described <ref type="bibr" target="#b15">[16]</ref>.</s><s>The microarray data can be obtained at the Gene Expression Omnibus (GEO) database repository (GSE57691; http://www.ncbi.nlm.nih.gov/geo/</s><s>info/linking.html).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of array data</head><p><s>The raw data matrix extracted from BeadStudio was uploaded into the GeneSpring GX version 11.5.1 (Agilent Technologies Pty Ltd) software for downstream analysis as previously described <ref type="bibr" target="#b15">[16]</ref>.</s><s>We sought to identify genes with a 2-fold differential expression within the aortas of patients with small AAA, large AAA or AOD compared to donor abdominal aortas based on corrected p value &lt; 0.05 by the Benjamini Hochberg false discovery rate (FDR) method and determined by non-parametric Mann-Whitney U test.</s><s>Genes showing ≥ 2-fold differences in expression between groups were considered to be significantly differentially expressed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative real-time reverse transcription polymerase chain reaction (qrt-Pcr)</head><p><s>Using total RNA obtained from a further 29 patients with small AAAs (n = 6), large AAAs (n = 9) and AOD (n = 8), and another 6 organ donor biopsies (validation group, Table <ref type="table" target="#tab_1">1</ref>) we assessed the validity of microarrays findings using qRT-PCR as described previously <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>Three genes associated with AAA (CTLA4, cytotoxic T-lymphocyte-associated protein 4; NKTR, natural killer cell triggering receptor; CD8A, CD8A molecule), and the uncoupling protein 2 gene (UCP2) associated with AOD were chosen for further assessment.</s><s>Mann-Whitney U test was performed to identify differences in expression levels of selected genes between small AAA, or large AAA, or AOD and control biopsies.</s><s>Data are reported as median and interquartile range.</s><s>All computations were performed using the SPSS statistical package v.17.0.2.</s><s>Statistical significance was defined at the conventional 5% level.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CD8</head><p><s>and CTLA4 proteins were immunohistochemically detected on 5-µm thick paraffin sections of AAA tissue taken from the maximally dilated aneurysm body as previously described <ref type="bibr" target="#b16">[17]</ref>.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: cd8+ lymphocytes and ctlA4 in large versus small AAA.</s><s>Immunohistochemical staining identifying the increased presence of CD8+ T cells (brown stain) in tissue from large AAA (A) versus small AAA (b) associated with lower detection of CTLA4 (red stain) in large (c) compared to small AAA (d); scale bar = 50 μm (A&amp;B) &amp; 100 μm (c&amp;d).</s></p></div></figDesc><graphic coords="3,191.58,353.87,228.85,333.73" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: distribution of differentially expressed genes in aortic aneurysmal and occlusive disease.</s><s>Venn diagrams depict the overlap among differentially expressed genes in patients with small and large abdominal aortic aneurysm (AAA) and aortic occlusive disease (AOD).</s><s>Shown are a number of upregulated (a) and downregulated (b) genes.</s><s>Patients with small or large AAA or AOD were compared with patients without AAA (Controls), (&gt; 2-fold difference, P value &lt; 0.05 calculated with non-parametric Mann-Whitney test and corrected by Benjamini and Hochberg method).</s></p></div></figDesc><graphic coords="3,63.60,50.40,484.80,242.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>). AAA and AOD cases were older compared to controls (mean age small AAAs 69.7±3.8,</s><s>large AAAs 71.5±7.8,</s><s>AOD 67.8±4.2, controls 42.7±12.5</s><s>years; P &lt; 0.05).</s><s>Mean maximum AAA diameter was 48.5±5.7 and 65.9±7.3</s><s>mm in patients with small and large AAAs, respectively.</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>table 1 : characteristics of subjects included in this study. characteristic discovery group Validation group small AAA large AAA Aod controls small AAA large AAA Aod controls</head><label>1</label><figDesc><div><p><s>AAA, abdominal aortic aneurysm; AOD, aortic occlusive disease; BMI, body mass index.</s><s>Nominal variables are presented as numbers; continuous variables are presented as mean ± standard deviation.</s><s>AAA or AOD were compared with controls.</s><s>Continuous variables were compared using Mann Whitney U test; nominal variables were compared using Fisher's exact test.</s></p></div></figDesc><table><row><cell>Number</cell><cell>20</cell><cell>29</cell><cell>9</cell><cell>10</cell><cell>6</cell><cell>9</cell><cell>8</cell><cell>6</cell></row><row><cell cols="2">Aortic diameter (mm) 53.4±2.3</cell><cell cols="4">68.4±14.3 19.6±2.6 25.7±1.2 48.5±5.7</cell><cell>65.9±7.3</cell><cell>-</cell><cell>-</cell></row><row><cell>Women</cell><cell>*0 (0%)</cell><cell>*2 (7%)</cell><cell cols="3">1 (11%) 4 (40%) 1 (17%)</cell><cell>2 (22%)</cell><cell>2 (25%)</cell><cell>2 (33%)</cell></row><row><cell>Age (years)</cell><cell>68.8±6.9</cell><cell>70.5±7.1</cell><cell cols="6">*61.6±9.3 68.4±4.5 *69.7±3.8 *71.5±7.8 *67.8±4.2 42.7±12.5</cell></row><row><cell>PAD</cell><cell>3 (15%)</cell><cell>5 (17%)</cell><cell cols="2">9 (100%) -</cell><cell>0 (0%)</cell><cell>0 (0%)</cell><cell cols="2">8 (100%) -</cell></row><row><cell>Hypertension</cell><cell>15 (75%)</cell><cell>25 (86%)</cell><cell cols="2">8 (89%) -</cell><cell>4 (67%)</cell><cell>6 (67%)</cell><cell>7 (88%)</cell><cell>-</cell></row><row><cell>Diabetes mellitus</cell><cell>4 (20%)</cell><cell>7 (24%)</cell><cell cols="2">1 (11%) -</cell><cell>4 (67%)</cell><cell>1 (11%)</cell><cell>1 (13%)</cell><cell>-</cell></row><row><cell>Dyslipidemia</cell><cell>15 (75%)</cell><cell>20 (69%)</cell><cell cols="2">8 (89%) -</cell><cell>6 (100%)</cell><cell>5 (56%)</cell><cell>6 (75%)</cell><cell>-</cell></row><row><cell cols="2">Coronary heart disease 8 (40 %)</cell><cell>17 (59%)</cell><cell cols="2">7 (78%) -</cell><cell>4 (67%)</cell><cell>5 (56%)</cell><cell>4 (50%)</cell><cell>-</cell></row><row><cell>Ever smoker</cell><cell>7 (35%)</cell><cell>21 (72%)</cell><cell cols="3">9 (100%) 5 (50%) 4 (67%)</cell><cell>6 (67%)</cell><cell cols="2">8 (100%) -</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>28.8±3.2</cell><cell>26.8±4.0</cell><cell cols="3">23.7±2.4 22.7±9.6 34.0±5.5</cell><cell>25.3±3.6</cell><cell cols="2">21.9±4.1 -</cell></row></table><note><p><s>Asterisk (*) indicates statistically significant differences compared to the control group (P &lt; 0.05).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>table 2 : top 10 KeGG pathways enriched in small and large abdominal aortic aneurysm.</head><label>2</label><figDesc><div><p><s>Whitney test and corrected by Benjamini and Hochberg method.</s><s>P value indicates the corrected significance of enrichment calculated from the hypergeometric test by Benjamini and Hochberg method.</s><s>Pathways were identified using WebGestalt and were linked to the KEGG (Kyoto Encyclopedia of Genes and Genomes) website http://www.</s><s>genome.jp/kegg/.</s></p></div></figDesc><table><row><cell>category</cell><cell>Pathway</cell><cell>KeGG</cell><cell>n</cell><cell>n</cell><cell>P value</cell></row><row><cell></cell><cell>Cytokine-cytokine receptor interaction</cell><cell cols="4">hsa04060 267 1.15*10 -14</cell></row><row><cell></cell><cell>Chemokine signaling pathway</cell><cell cols="4">hsa04062 190 4.50*10 -11</cell></row><row><cell></cell><cell>Hematopoietic cell lineage</cell><cell cols="2">hsa04640 88</cell><cell></cell><cell>3.68*10 -08</cell></row><row><cell></cell><cell>NOD-like receptor signaling pathway</cell><cell cols="2">hsa04621 62</cell><cell></cell><cell>1.18*10 -07</cell></row><row><cell>Small AAA-upregulated genes</cell><cell>Cell adhesion molecules (CAMs) Jak-STAT signaling pathway</cell><cell cols="2">hsa04514 134 hsa04630 155</cell><cell></cell><cell>4.15*10 -07 9.36*10 -07</cell></row><row><cell></cell><cell>Intestinal immune network for IgA production</cell><cell cols="2">hsa04672 50</cell><cell></cell><cell>4.07*10 -05</cell></row><row><cell></cell><cell>T cell receptor signaling pathway</cell><cell cols="2">hsa04660 108</cell><cell></cell><cell>4.07*10 -05</cell></row><row><cell></cell><cell>Cytosolic DNA-sensing pathway</cell><cell cols="2">hsa04623 56</cell><cell></cell><cell>5.46*10 -05</cell></row><row><cell></cell><cell>Pathways in cancer</cell><cell cols="2">hsa05200 330</cell><cell></cell><cell>8.39*10 -05</cell></row><row><cell></cell><cell>Ribosome</cell><cell cols="2">hsa03010 88</cell><cell></cell><cell>2.50*10 -26</cell></row><row><cell></cell><cell>Metabolic pathways</cell><cell cols="4">hsa01100 1104 2.30*10 -22</cell></row><row><cell></cell><cell>Oxidative phosphorylation</cell><cell cols="4">hsa00190 135 4.25*10 -20</cell></row><row><cell></cell><cell>Parkinson's disease</cell><cell cols="4">hsa05012 133 3.60*10 -19</cell></row><row><cell>Small AAA-downregulated genes</cell><cell>Alzheimer's disease Huntington's disease</cell><cell cols="4">hsa05010 169 6.00*10 -19 hsa05016 185 6.00*10 -19</cell></row><row><cell></cell><cell>Focal adhesion</cell><cell cols="4">hsa04510 201 5.48*10 -13</cell></row><row><cell></cell><cell>Cardiac muscle contraction</cell><cell cols="2">hsa04260 79</cell><cell></cell><cell>7.66*10 -12</cell></row><row><cell></cell><cell cols="3">Arrhythmogenic right ventricular cardiomyopathy hsa05412 76</cell><cell></cell><cell>1.65*10 -07</cell></row><row><cell></cell><cell>Vascular smooth muscle contraction</cell><cell cols="4">hsa04270 115 1.65*10 -07</cell></row><row><cell></cell><cell>Cytokine-cytokine receptor interaction</cell><cell cols="4">hsa04060 267 2.52*10 -17</cell></row><row><cell></cell><cell>Chemokine signaling pathway</cell><cell cols="4">hsa04062 190 3.53*10 -12</cell></row><row><cell></cell><cell>Hematopoietic cell lineage</cell><cell cols="2">hsa04640 88</cell><cell></cell><cell>9.95*10 -11</cell></row><row><cell></cell><cell>Primary immunodeficiency</cell><cell cols="2">hsa05340 35</cell><cell></cell><cell>1.89*10 -09</cell></row><row><cell>Large AAA-upregulated genes</cell><cell>Cell adhesion molecules (CAMs) Intestinal immune network for IgA production</cell><cell cols="2">hsa04514 134 hsa04672 50</cell><cell></cell><cell>7.87*10 -08 6.70*10 -07</cell></row><row><cell></cell><cell>Cytosolic DNA-sensing pathway</cell><cell cols="2">hsa04623 56</cell><cell></cell><cell>1.15*10 -06</cell></row><row><cell></cell><cell>NOD-like receptor signaling pathway</cell><cell cols="2">hsa04621 62</cell><cell></cell><cell>1.86*10 -06</cell></row><row><cell></cell><cell>Jak-STAT signaling pathway</cell><cell cols="2">hsa04630 155</cell><cell></cell><cell>2.30*10 -06</cell></row><row><cell></cell><cell>T cell receptor signaling pathway</cell><cell cols="2">hsa04660 108</cell><cell></cell><cell>2.40*10 -06</cell></row><row><cell></cell><cell>Metabolic pathways</cell><cell cols="4">hsa01100 1104 1.05*10 -24</cell></row><row><cell></cell><cell>Huntington's disease</cell><cell cols="4">hsa05016 185 3.64*10 -20</cell></row><row><cell></cell><cell>Oxidative phosphorylation</cell><cell cols="4">hsa00190 135 8.60*10 -20</cell></row><row><cell></cell><cell>Alzheimer's disease</cell><cell cols="4">hsa05010 169 2.45*10 -18</cell></row><row><cell>Large AAA-downregulated genes</cell><cell>Parkinson's disease Ribosome</cell><cell cols="4">hsa05012 133 7.70*10 -18 hsa03010 88 1.32*10 -13</cell></row><row><cell></cell><cell>Cardiac muscle contraction</cell><cell cols="2">hsa04260 79</cell><cell></cell><cell>4.25*10 -12</cell></row><row><cell></cell><cell>Focal adhesion</cell><cell cols="4">hsa04510 201 8.41*10 -12</cell></row><row><cell></cell><cell>Vascular smooth muscle contraction</cell><cell cols="4">hsa04270 115 1.27*10 -10</cell></row><row><cell></cell><cell>Fatty acid metabolism</cell><cell cols="2">hsa00071 42</cell><cell></cell><cell>1.70*10 -08</cell></row><row><cell cols="6">AAA, abdominal aortic aneurysm; N, number of reference genes in the pathway; n, number of genes differentially expressed</cell></row><row><cell cols="6">in pathway in small or large AAA compared to patients without AAA (Controls); &gt; 2-fold difference, P value &lt; 0.05 calculated</cell></row><row><cell>with non-parametric Mann-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>table 3 : examples of differentially expressed genes in small and large AAA with some connection to immunity.</head><label>3</label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell>small AAA</cell><cell></cell><cell>large AAA</cell><cell></cell></row><row><cell cols="2">symbol name</cell><cell>Fold change</cell><cell>corrected P value</cell><cell>Fold change</cell><cell>corrected P value</cell></row><row><cell>IL1B</cell><cell>interleukin 1, beta</cell><cell>5.08</cell><cell>0.002</cell><cell>3.85</cell><cell>0.001</cell></row><row><cell>IL6</cell><cell>interleukin 6</cell><cell>6.28</cell><cell>0.004</cell><cell>6.48</cell><cell>0.002</cell></row><row><cell>IL8</cell><cell>interleukin 8</cell><cell>4.49</cell><cell>0.005</cell><cell>3.65</cell><cell>0.004</cell></row><row><cell cols="2">CXCL2 chemokine (C-X-C motif) ligand 2</cell><cell>3.35</cell><cell>0.004</cell><cell>2.73</cell><cell>0.005</cell></row><row><cell cols="2">CXCL13 chemokine (C-X-C motif) ligand 13</cell><cell>2.21</cell><cell>0.013</cell><cell>3.09</cell><cell>0.002</cell></row><row><cell cols="2">CCL3L3 chemokine (C-C motif) ligand 3-like 3</cell><cell>3.14</cell><cell>0.039</cell><cell>2.59</cell><cell>0.041</cell></row><row><cell cols="2">CCL4L2 chemokine (C-C motif) ligand 4-like 2</cell><cell>2.48</cell><cell>0.021</cell><cell>2.12</cell><cell>0.023</cell></row><row><cell>CD69</cell><cell>CD69 molecule</cell><cell>2.67</cell><cell>0.039</cell><cell>3.45</cell><cell>0.004</cell></row><row><cell>CD19</cell><cell>CD19 antigen</cell><cell>2.79</cell><cell>0.026</cell><cell>4.45</cell><cell>0.002</cell></row><row><cell>NKTR</cell><cell>natural killer-tumor recognition sequence</cell><cell>2.37</cell><cell>0.002</cell><cell>2.66</cell><cell>0.001</cell></row><row><cell>CTLA4</cell><cell>cytotoxic T-lymphocyte-associated protein 4</cell><cell>2.01</cell><cell>0.018</cell><cell>-</cell><cell>-</cell></row><row><cell>CD8A</cell><cell>CD8 antigen, alpha chain</cell><cell>-</cell><cell>-</cell><cell>2.24</cell><cell>0.012</cell></row><row><cell cols="3">CD79A CD79A antigen, immunoglobulin-associated alpha -</cell><cell>-</cell><cell>2.76</cell><cell>0.005</cell></row><row><cell cols="3">CD79B CD79b molecule, immunoglobulin-associated beta -</cell><cell>-</cell><cell>3.43</cell><cell>0.004</cell></row><row><cell>FCRL2</cell><cell>Fc receptor-like 2</cell><cell>-</cell><cell>-</cell><cell>2.53</cell><cell>0.002</cell></row><row><cell>FCRL5</cell><cell>Fc receptor-like 5</cell><cell>-</cell><cell>-</cell><cell>2.01</cell><cell>0.001</cell></row><row><cell cols="2">FCRLA Fc receptor-like A</cell><cell>-</cell><cell>-</cell><cell>3.15</cell><cell>0.009</cell></row></table><note><p><s>AAA, abdominal aortic aneurysm.</s><s>Differentially expressed genes were determined by comparison of patients with small or large AAA with patients without AAA (Controls), (&gt; 2-fold change, P value &lt; 0.05 calculated with non-parametric Mann-Whitney test and corrected by Benjamini and Hochberg method).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>table 4 : top 10 KeGG pathways enriched in aortic occlusive disease.</head><label>4</label><figDesc></figDesc><table><row><cell>category</cell><cell>Pathway</cell><cell>KeGG</cell><cell>n</cell><cell>n</cell><cell>P value</cell></row><row><cell></cell><cell>Metabolic pathways</cell><cell>hsa01100</cell><cell>1104</cell><cell cols="2">147 1.49*10 -43</cell></row><row><cell></cell><cell>Oxidative phosphorylation</cell><cell>hsa00190</cell><cell>135</cell><cell>49</cell><cell>5.68*10 -35</cell></row><row><cell></cell><cell>Parkinson's disease</cell><cell>hsa05012</cell><cell>133</cell><cell>46</cell><cell>7.03*10 -32</cell></row><row><cell></cell><cell>Huntington's disease</cell><cell>hsa05016</cell><cell>185</cell><cell>52</cell><cell>4.11*10 -31</cell></row><row><cell>AOD-upregulated genes</cell><cell>Alzheimer's disease Ribosome</cell><cell>hsa05010 hsa03010</cell><cell>169 88</cell><cell>48 35</cell><cell>5.02*10 -29 6.28*10 -27</cell></row><row><cell></cell><cell>Focal adhesion</cell><cell>hsa04510</cell><cell>201</cell><cell>38</cell><cell>1.90*10 -16</cell></row><row><cell></cell><cell>Spliceosome</cell><cell>hsa03040</cell><cell>128</cell><cell>29</cell><cell>8.16*10 -15</cell></row><row><cell></cell><cell>Cardiac muscle contraction</cell><cell>hsa04260</cell><cell>79</cell><cell>21</cell><cell>2.63*10 -12</cell></row><row><cell></cell><cell>Proteasome</cell><cell>hsa03050</cell><cell>48</cell><cell>17</cell><cell>2.63*10 -12</cell></row><row><cell></cell><cell cols="2">Cytokine-cytokine receptor interaction hsa04060</cell><cell>267</cell><cell>8</cell><cell>5.69*10 -07</cell></row><row><cell></cell><cell>Hematopoietic cell lineage</cell><cell>hsa04640</cell><cell>88</cell><cell>5</cell><cell>5.93*10 -06</cell></row><row><cell></cell><cell>Chemokine signaling pathway</cell><cell>hsa04062</cell><cell>190</cell><cell>6</cell><cell>8.64*10 -06</cell></row><row><cell></cell><cell>Regulation of actin cytoskeleton</cell><cell>hsa04810</cell><cell>216</cell><cell>5</cell><cell>2.00*10 -04</cell></row><row><cell>AOD-downregulated genes</cell><cell>Graft-versus-host disease Jak-STAT signaling pathway</cell><cell>hsa05332 hsa04630</cell><cell>42 155</cell><cell>3 4</cell><cell>3.00*10 -04 6.00*10 -04</cell></row><row><cell></cell><cell>Pathogenic Escherichia coli infection</cell><cell>hsa05130</cell><cell>59</cell><cell>3</cell><cell>6.00*10 -04</cell></row><row><cell></cell><cell>NOD-like receptor signaling pathway</cell><cell>hsa04621</cell><cell>62</cell><cell>3</cell><cell>6.00*10 -04</cell></row><row><cell></cell><cell>Toll-like receptor signaling pathway</cell><cell>hsa04620</cell><cell>101</cell><cell>3</cell><cell>2.10*10 -04</cell></row><row><cell></cell><cell>Prion diseases</cell><cell>hsa05020</cell><cell>35</cell><cell>2</cell><cell>3.70*10 -04</cell></row></table><note><p><s>AOD, aortic occlusive disease; N, number of reference genes in the pathway; n, number of genes differentially expressed in pathway in AOD compared to patients without AAA (Controls); &gt; 2-fold difference, P value &lt; 0.05 calculated with non-parametric Mann-Whitney test and corrected by Benjamini and Hochberg method.</s><s>P value indicates the corrected significance of enrichment calculated from the hypergeometric test by Benjamini and Hochberg method.</s><s>Pathways were identified using WebGestalt and were linked to the KEGG (Kyoto Encyclopedia of Genes and Genomes) website http://www.genome.jp/kegg/.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>table 5 : examples of differentially expressed genes in Aod.</head><label>5</label><figDesc></figDesc><table><row><cell>symbol</cell><cell>name</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>table 6 : Validation of genes differentially expressed in AAA or Aod by qrt-Pcr.</head><label>6</label><figDesc></figDesc><table><row><cell>Gene</cell><cell>sample</cell><cell cols="2">n Median</cell><cell>IQr</cell><cell>Fold change</cell><cell>P</cell></row><row><cell></cell><cell>Small AAA Normal control</cell><cell>6 6</cell><cell>202.161 18.185</cell><cell>120.109-376.825 10.526-24.477</cell><cell>11.12</cell><cell>0.002</cell></row><row><cell>CTLA4</cell><cell>Large AAA Normal control</cell><cell>9 6</cell><cell>65.239 18.185</cell><cell>17.268-176.354 10.526-24.477</cell><cell>3.59</cell><cell>0.065</cell></row><row><cell></cell><cell>Small AAA Large AAA</cell><cell>6 9</cell><cell>202.161 65.239</cell><cell>120.109-376.825 17.268-176.354</cell><cell>3.10</cell><cell>0.041</cell></row><row><cell></cell><cell>Small AAA Normal control</cell><cell>6 6</cell><cell>61.004 38.194</cell><cell>51.980-69.598 18.075-46.661</cell><cell>1.60</cell><cell>0.132</cell></row><row><cell>CD8A</cell><cell>Large AAA Normal control</cell><cell>9 6</cell><cell>109.487 38.194</cell><cell>61.730-176.194 18.075-46.661</cell><cell>2.87</cell><cell>0.004</cell></row><row><cell></cell><cell>Small AAA Large AAA</cell><cell>6 9</cell><cell>61.004 109.487</cell><cell>51.980-69.598 61.730-176.194</cell><cell>-1.79</cell><cell>0.065</cell></row><row><cell></cell><cell>Small AAA Normal control</cell><cell>6 6</cell><cell>0.651 0.391</cell><cell>0.349-0.695 0.381-0.404</cell><cell>1.66</cell><cell>0.041</cell></row><row><cell>NKTR</cell><cell>Large AAA Normal control</cell><cell>9 6</cell><cell>1.186 0.391</cell><cell>0.771-1.923 0.381-0.404</cell><cell>3.03</cell><cell>0.015</cell></row><row><cell></cell><cell>Small AAA Large AAA</cell><cell>6 9</cell><cell>0.651 1.186</cell><cell>0.349-0.695 0.771-1.923</cell><cell>-1.82</cell><cell>0.040</cell></row><row><cell>UCP2</cell><cell>AOD Normal control</cell><cell>8 6</cell><cell>0.729 2.306</cell><cell>0.545-0.737 0.909-5.070</cell><cell>-3.16</cell><cell>0.017</cell></row></table><note><p><s>AAA, abdominal aortic aneurysm; AOD, aortic occlusive disease; N, number of samples; Median, median gene expression relative to reference gene (ACTB); IQR, interquartile range; P, two-sided P value by Mann-Whitney U test.</s><s>www.impactjournals.com/oncotarget</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.impactjournals.com/oncotarget</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AcKnowledGeMents</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>conFlIcts oF Interests</head><p><s>The author(s) declare that they have no conflict of interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) summary of recommendations</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Haskal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Hertzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Bakal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Creager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halperin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Hiratzka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Olin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Puschett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Rosenfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sacks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stanley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Vasc Interv Radiol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1383" to="1397" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Systematic comparison of the early outcome of angioplasty and endarterectomy for symptomatic carotid artery disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Greenhalgh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Davies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1439" to="1443" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Froehlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Avezum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Budaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Kline-Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>López-Sendón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Allegrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Eagle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><surname>Grace Investigators</surname></persName>
		</author>
		<ptr target="www.impactjournals.com/oncotarget1128" />
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page">1123</biblScope>
			<date type="published" when="2006">2006. 12995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Norman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1075" to="1077" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Abdominal aortic aneurysm: pathogenesis and implications for management</title>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daugherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Norman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2605" to="2613" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cornuz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sidoti</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tevaearai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Public Health</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="343" to="349" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Determinants of aneurysmal aortic disease</title>
		<author>
			<persName><forename type="first">N</forename><surname>Diehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Baumgartner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="2134" to="2135" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Incidence of cancer and abdominal aortic aneurysms. A logistic regression analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Belem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Ciocca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Cody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Mackenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Graham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">800</biblScope>
			<biblScope unit="page" from="68" to="73" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response</title>
		<author>
			<persName><forename type="first">D</forename><surname>Shteinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Halak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shapiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kinarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sobol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lahat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Karmeli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Vasc Endovasc Surg</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="462" to="465" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mouse models of abdominal aortic aneurysms</title>
		<author>
			<persName><forename type="first">A</forename><surname>Daugherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cassis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="429" to="434" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Global expression profiles in human normal and aneurysmal abdominal aorta based on two distinct whole genome microarray platforms</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Lenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tromp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Skunca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gatalica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Berguer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuivaniemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1085</biblScope>
			<biblScope unit="page" from="360" to="362" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Lenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tromp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weinsheimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gatalica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Berguer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuivaniemi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Genomics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">237</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture</title>
		<author>
			<persName><forename type="first">E</forename><surname>Choke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Cockerill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Loftus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Vasc Endovasc Surg</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="305" to="310" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nyara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Moxon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trollope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Genomics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">298</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Spin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Azuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Tedesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Dyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Maegdefessel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dalman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Tsao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Genomics</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="993" to="1003" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Differential gene expression in the proximal neck of human abdominal aortic aneurysm</title>
		<author>
			<persName><forename type="first">E</forename><surname>Biros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gäbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lindeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nataatmadja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Holdt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hinterseher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pilarsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="page" from="211" to="218" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155</title>
		<author>
			<persName><forename type="first">E</forename><surname>Biros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cardinal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci (Lond)</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="795" to="803" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Enhanced expression and activation of proinflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6-and IL-8-dominated inflammatory responses prevail in the human aneurysm</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lindeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Abdul-Hussien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Schaapherder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Van Bockel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Der Thüsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Roelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Kleemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Sci (Lond)</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="687" to="697" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Is CTLA-4 a master switch for peripheral T cell tolerance?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bluestone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1989" to="1993" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Henderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Geng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Sukhova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Whittemore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="96" to="104" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Dobrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Anidjar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chejfec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mrkvicka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">800</biblScope>
			<biblScope unit="page" from="74" to="88" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lindeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Abdul-Hussien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Van Bockel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wolterbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kleemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="2209" to="2216" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients</title>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Terabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hirano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujibayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Oguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fukaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Rheumatol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="904" to="912" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Conaghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Durez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Alten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Burmester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Tak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Klareskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Catrina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dicarlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gaillez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Bars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Peterfy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1287" to="1294" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Tolerability and efficacy of abatacept in Japanese patients with rheumatoid arthritis: a phase I study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Matsubara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tohma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kohsaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ozaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Miyasaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hiraoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Abe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Rheumatol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="634" to="645" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Genovese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Luggen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Le Bars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Elegbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dougados</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1546" to="1554" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Use of abatacept in rheumatoid www.impactjournals.com/oncotarget arthritis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Von Kempis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dudler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hasler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kyburz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tyndall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zufferey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Villiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Swiss Med Wkly</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page">13581</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mitochondrial complex I deficiency in Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Schapira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dexter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Marsden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="823" to="827" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">PGC-1 coactivators: inducible regulators of energy metabolism in health and disease</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Finck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="615" to="622" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Peroxisome proliferatoractivated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism</title>
		<author>
			<persName><forename type="first">C</forename><surname>Handschin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Spiegelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="728" to="735" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378</title>
		<author>
			<persName><forename type="first">M</forename><surname>Carrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Grueter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Frisard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hulver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bassel-Duby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Olson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="15330" to="15335" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The intravenous glucose tolerance test in atherosclerotic disease with special reference to obestity hypertension, diabetic heredity and cholesterol values</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wahlberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Med Scand</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="1962">1962</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Composition and synthesis of fatty acids in atherosclerotic aortas of the pigeon</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Clair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Lofland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Clarkson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="739" to="747" />
			<date type="published" when="1968">1968</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Wip1-dependent regulation of autophagy, obesity, and atherosclerosis</title>
		<author>
			<persName><forename type="first">Le</forename><surname>Guezennec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Brichkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Kostromina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Bulavin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="68" to="80" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Finck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Standley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Maclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bernal-Mizrachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Muslin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Kastan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Semenkovich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="377" to="389" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">p53 is required for chloroquine-induced atheroprotection but not insulin sensitization</title>
		<author>
			<persName><forename type="first">B</forename><surname>Razani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Semenkovich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1738" to="1746" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pecqueur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Couplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bouillaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ricquier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="48" to="56" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nègre-Salvayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hirtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Carrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cazenave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Troly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Salvayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Penicaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Casteilla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="809" to="815" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production</title>
		<author>
			<persName><forename type="first">D</forename><surname>Arsenijevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Onuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pecqueur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Raimbault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Manning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Miroux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Couplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Alves-Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goubern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Surwit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bouillaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Collins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="435" to="439" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Protective role of uncoupling protein 2 in atherosclerosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Blanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Alves-Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Esposito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rousset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gourdy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ricquier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tedgui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Miroux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mallat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="388" to="390" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Koh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1200" to="1207" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Son</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1022" to="1028" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Uncoupling protein-2 protects endothelial function in diet-induced obese mice</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Cheang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="1211" to="1216" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mitochondrial reactive oxygen species. Contribution to oxidative stress and interorganellar signaling</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rhoads</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Umbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Subbaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Siedow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plant Physiol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="357" to="366" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Autophagy in health and disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Carreira</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Mitophagy as a way of life</title>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="page" from="C203" to="C210" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Complement activation after oxidative stress: role of the lectin complement pathway</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Collard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Väkevä</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Morrissey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Agah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rollins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Reenstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Buras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Stahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="1549" to="1556" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The role of complement in atherosclerosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Haskard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Mason</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Lipidol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="478" to="482" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
